[go: up one dir, main page]

WO2009131698A3 - N-acétyl-alpha-d-glucosaminidase (naglu) phosphorylée recombinée et ses applications - Google Patents

N-acétyl-alpha-d-glucosaminidase (naglu) phosphorylée recombinée et ses applications Download PDF

Info

Publication number
WO2009131698A3
WO2009131698A3 PCT/US2009/002529 US2009002529W WO2009131698A3 WO 2009131698 A3 WO2009131698 A3 WO 2009131698A3 US 2009002529 W US2009002529 W US 2009002529W WO 2009131698 A3 WO2009131698 A3 WO 2009131698A3
Authority
WO
WIPO (PCT)
Prior art keywords
naglu
glucosaminidase
acetyl
alpha
phosphorylated recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/002529
Other languages
English (en)
Other versions
WO2009131698A2 (fr
Inventor
Norman Matthew Ellinwood
Rafi Simon Awedikian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iowa State University Research Foundation Inc ISURF
Original Assignee
Iowa State University Research Foundation Inc ISURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iowa State University Research Foundation Inc ISURF filed Critical Iowa State University Research Foundation Inc ISURF
Publication of WO2009131698A2 publication Critical patent/WO2009131698A2/fr
Publication of WO2009131698A3 publication Critical patent/WO2009131698A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04045—N-Acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (3.1.4.45)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0105—Alpha-N-acetylglucosaminidase (3.2.1.50)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne de façon générale des protéines de fusion phosphorylées recombinées NaGlu, la production des protéines de fusion phosphorylées recombinées NaGlu et leurs applications.
PCT/US2009/002529 2008-04-23 2009-04-23 N-acétyl-alpha-d-glucosaminidase (naglu) phosphorylée recombinée et ses applications Ceased WO2009131698A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4736208P 2008-04-23 2008-04-23
US61/047,362 2008-04-23

Publications (2)

Publication Number Publication Date
WO2009131698A2 WO2009131698A2 (fr) 2009-10-29
WO2009131698A3 true WO2009131698A3 (fr) 2010-05-27

Family

ID=41217336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/002529 Ceased WO2009131698A2 (fr) 2008-04-23 2009-04-23 N-acétyl-alpha-d-glucosaminidase (naglu) phosphorylée recombinée et ses applications

Country Status (1)

Country Link
WO (1) WO2009131698A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20170938A1 (es) 2010-06-25 2017-07-13 Shire Human Genetic Therapies Suministro al sistema nervioso central de agentes terapeuticos
EP2596123B1 (fr) * 2010-07-22 2015-11-25 Shire Human Genetic Therapies, Inc. Structure cristalline de l'alpha-n-acétylglucosaminidase humaine
AU2012322811A1 (en) * 2011-10-12 2014-05-01 Synageva Biopharma Corp. Recombinant human NaGlu protein and uses thereof
US10196668B2 (en) 2013-09-05 2019-02-05 University Of Washington Through Its Center For Commercialization Reagents and methods for screening MPS I, II, IIIA, IIIB, IVA, VI, and VII
US20170267986A1 (en) * 2014-06-25 2017-09-21 Shire Human Genetic Therapies, Inc. Generation of mannose-6-phosphate containing recombinant alpha-n-acetyl glucosaminidase
AU2018375163A1 (en) * 2017-11-30 2020-06-11 The Trustees Of The University Of Pennsylvania Gene therapy for mucopolysaccharidosis IIIB
WO2021194915A1 (fr) * 2020-03-23 2021-09-30 The University Of North Carolina At Chapel Hill Vecteurs aav-naglu pour le traitement de la mucopolysaccharidose iiib

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020019040A1 (en) * 2000-03-27 2002-02-14 Noteborn Mathieu Hubertus M. Apoptin-associating protein
US20030039643A1 (en) * 1995-11-23 2003-02-27 Hopwood John Joseph Synthetic mammalian alpha-N-acetylglucosaminidase and genetic sequences encoding same
US20060198833A1 (en) * 2003-06-05 2006-09-07 The Salk Institute For Biological Studies Compositions and methods for targeting a polypeptide to the central nervous system
US20080014188A1 (en) * 2004-02-06 2008-01-17 Zankel Todd C Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039643A1 (en) * 1995-11-23 2003-02-27 Hopwood John Joseph Synthetic mammalian alpha-N-acetylglucosaminidase and genetic sequences encoding same
US20020019040A1 (en) * 2000-03-27 2002-02-14 Noteborn Mathieu Hubertus M. Apoptin-associating protein
US20060198833A1 (en) * 2003-06-05 2006-09-07 The Salk Institute For Biological Studies Compositions and methods for targeting a polypeptide to the central nervous system
US20080014188A1 (en) * 2004-02-06 2008-01-17 Zankel Todd C Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof

Also Published As

Publication number Publication date
WO2009131698A2 (fr) 2009-10-29

Similar Documents

Publication Publication Date Title
WO2013184939A3 (fr) Polypeptides hybrides comprenant une protéine active liée à un polypeptide à domaine mucin
IL250938A0 (en) Enzymatic fusion proteins, preparations containing them and their uses
WO2012058517A3 (fr) Membranes à nanofils céramiques et procédés de fabrication associés
IL218296A0 (en) Obpgplys/endolysin polypeptides, fusion proteins and compositions compriisng the same and uses thereof
EP4491226A3 (fr) Variants fc optimisés
SG162687A1 (en) Caustic stable chromatography ligands
WO2006131564A3 (fr) Nouvelles proteines de fusion de type hydrophobines appauvries en cysteine, leur production, et leur utilisation
WO2008021156A3 (fr) Anticorps dirigés contre l'il-17a
WO2013040093A3 (fr) Compositions de peptide-2 de type glucagon et leurs procédés de fabrication et d'utilisation
NZ596658A (en) Dig-10 insecticidal cry toxins
WO2011095740A3 (fr) Confiseries aux proteines de pois
WO2010120514A3 (fr) Protéines liant des antigènes comprenant des échafaudages protéiniques internes recombinants
CA2705357C (fr) Formulations pour proteines hybrides taci-immunoglobuline
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2007087384A3 (fr) Procédés de modulation de la teneur en mannose de protéines de recombinaison
WO2011133704A3 (fr) Protéines et polypeptides modifiés et leurs utilisations
WO2010034032A3 (fr) Procédés pour préparer des compositions de polypeptide purifié
WO2008121767A3 (fr) Polypeptides cousus
WO2006082251A3 (fr) Nouvelles proteines de fusion d'hydrophobine, leur production et leur utilisation
WO2009131698A3 (fr) N-acétyl-alpha-d-glucosaminidase (naglu) phosphorylée recombinée et ses applications
WO2012068317A3 (fr) Procédés de production de protéines recombinantes
WO2010009879A3 (fr) Procédés de production de paricalcitol
WO2010102778A3 (fr) 3-aminoisoxazolopyridines substituées en tant que modulateurs de kcnq 2/3
WO2012049307A3 (fr) Nouveaux dérivés d'insuline à extrémité n modifiée
WO2009115084A3 (fr) Nouveaux dérivés de pyrrolopyrimidine et leurs utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09734519

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09734519

Country of ref document: EP

Kind code of ref document: A2